106 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
plan focused on malignancies with unmet needs that are targets for this mechanism of action. While there is scientific rationale for potential broad
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall have
424B5
WINT
Windtree Therapeutics Inc
9 Nov 23
Prospectus supplement for primary offering
4:11pm
,” “should,” “projects,” “plans,” “goal,” “targets,” “potential,” “estimates,” “pro forma,” “seeks,” “intends” or “anticipates” or the negative thereof
424B5
2mxgj2p39yxa0zfj
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
29g sznh0
22 Mar 21
Prospectus supplement for primary offering
4:39pm